Latest filing published 23 Dec 2024 for Lamb Weston Holdings, Inc., €73k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -33.3%Entry US$63.69 · Close at T+365 US$42.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles A. Blixt: trading record in brief
Charles A. Blixt, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lamb Weston Holdings, Inc., Gyre Therapeutics, Inc. and Krispy Kreme Doughnuts Inc. Over a trading history stretching from 18 April 2006 to 23 December 2024, the count stands at 27 filings.
Market trades split into 1 purchase (€73k) and 3 sales (€650k). Netting one side against the other leaves €577k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants and 3 option exercises. So far in 2024, the count stands at 1 purchase and no sales.
The newest entry dates from 23 December 2024: an open-market purchase of €73k, in Lamb Weston Holdings, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles A. Blixt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,200 shares@ US$63.2507100.0% of flowCommon StockSEC:0001415889-24-030098:0Canonical exit: 23 Mar 2025 (T+90)
- 2,469 shares0Common StockSEC:0001415889-24-024837:0
- 2,043 shares0Common StockSEC:0001415889-23-014285:0
- 1,873 shares0Common StockSEC:0001415889-22-010809:0
- 2,807 shares0Common StockSEC:0001179110-21-009335:0
- 1,912 shares0Common StockSEC:0001179110-20-010411:0
- 1,800 shares0Common StockSEC:0001179110-19-010869:0
- 1,911 shares0Common StockSEC:0001179110-18-012097:0
- 8.53 sharesCommon StockSEC:0001179110-17-014909:0
- 12.06 sharesCommon StockSEC:0001179110-17-014909:1
- 3,528 shares0Common StockSEC:0001179110-17-013217:0
- 10.14 sharesCommon StockSEC:0001179110-17-012071:0
- 9.8 sharesCommon StockSEC:0001179110-17-008596:0
- 1,750 shares0Common StockSEC:0001209191-15-030202:0
- 22,250 shares@ US$20.00Common StockSEC:0001209191-15-030202:1
- 10,000 shares0Common StockSEC:0001181431-14-038782:0
- 7,500 shares@ US$7.10Common StockSEC:0001140361-10-046445:0
- 2,000 shares@ US$9.27Common StockSEC:0001140361-10-046445:1
- 9,500 shares@ US$21.80Common StockSEC:0001140361-10-046445:2
- 5,500 shares@ US$9.27Common StockSEC:0001140361-10-046445:3
- 5,500 shares@ US$21.76Common StockSEC:0001140361-10-046445:4
- 6,000 shares0Common StockSEC:0001209191-07-035275:0
- 6,000 shares0Common StockSEC:0001209191-07-024375:0
- 6,000 shares0Common Stock, no par valueSEC:0001209191-06-063358:0
- 6,000 shares0Common Stock, no par valueSEC:0001209191-06-062534:0
25 of 27 declarations
